LZAGY
Price
$71.60
Change
+$0.44 (+0.62%)
Updated
Jul 25 closing price
Capitalization
43.14B
87 days until earnings call
MDRSF
Price
$66.68
Change
-$12.31 (-15.58%)
Updated
Oct 21 closing price
Capitalization
1.15B
Interact to see
Advertisement

LZAGY vs MDRSF

Header iconLZAGY vs MDRSF Comparison
Open Charts LZAGY vs MDRSFBanner chart's image
Lonza Group AG
Price$71.60
Change+$0.44 (+0.62%)
Volume$12.23K
Capitalization43.14B
MEDARTIS HOLDING AG
Price$66.68
Change-$12.31 (-15.58%)
Volume$500
Capitalization1.15B
LZAGY vs MDRSF Comparison Chart in %
Loading...
LZAGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LZAGY vs. MDRSF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LZAGY is a Buy and MDRSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (LZAGY: $71.60 vs. MDRSF: $66.68)
Brand notoriety: LZAGY and MDRSF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LZAGY: 17% vs. MDRSF: 100%
Market capitalization -- LZAGY: $43.14B vs. MDRSF: $1.15B
LZAGY [@Medical Specialties] is valued at $43.14B. MDRSF’s [@Medical Specialties] market capitalization is $1.15B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LZAGY’s FA Score shows that 1 FA rating(s) are green whileMDRSF’s FA Score has 0 green FA rating(s).

  • LZAGY’s FA Score: 1 green, 4 red.
  • MDRSF’s FA Score: 0 green, 5 red.
According to our system of comparison, LZAGY is a better buy in the long-term than MDRSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LZAGY’s TA Score shows that 4 TA indicator(s) are bullish.

  • LZAGY’s TA Score: 4 bullish, 3 bearish.

Price Growth

LZAGY (@Medical Specialties) experienced а +1.04% price change this week, while MDRSF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

LZAGY is expected to report earnings on Oct 21, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LZAGY($43.1B) has a higher market cap than MDRSF($1.15B). LZAGY YTD gains are higher at: 23.516 vs. MDRSF (0.000). LZAGY has higher annual earnings (EBITDA): 1.42B vs. MDRSF (11.7M). LZAGY has more cash in the bank: 2.15B vs. MDRSF (20.6M). MDRSF has less debt than LZAGY: MDRSF (27.5M) vs LZAGY (2.91B). LZAGY has higher revenues than MDRSF: LZAGY (6.32B) vs MDRSF (183M).
LZAGYMDRSFLZAGY / MDRSF
Capitalization43.1B1.15B3,748%
EBITDA1.42B11.7M12,103%
Gain YTD23.5160.000-
P/E Ratio32.68N/A-
Revenue6.32B183M3,453%
Total Cash2.15B20.6M10,427%
Total Debt2.91B27.5M10,582%
FUNDAMENTALS RATINGS
LZAGY vs MDRSF: Fundamental Ratings
LZAGY
MDRSF
OUTLOOK RATING
1..100
5546
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
6640
SMR RATING
1..100
9390
PRICE GROWTH RATING
1..100
5276
P/E GROWTH RATING
1..100
82100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LZAGY's Valuation (23) in the null industry is significantly better than the same rating for MDRSF (90). This means that LZAGY’s stock grew significantly faster than MDRSF’s over the last 12 months.

MDRSF's Profit vs Risk Rating (40) in the null industry is in the same range as LZAGY (66). This means that MDRSF’s stock grew similarly to LZAGY’s over the last 12 months.

MDRSF's SMR Rating (90) in the null industry is in the same range as LZAGY (93). This means that MDRSF’s stock grew similarly to LZAGY’s over the last 12 months.

LZAGY's Price Growth Rating (52) in the null industry is in the same range as MDRSF (76). This means that LZAGY’s stock grew similarly to MDRSF’s over the last 12 months.

LZAGY's P/E Growth Rating (82) in the null industry is in the same range as MDRSF (100). This means that LZAGY’s stock grew similarly to MDRSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LZAGYMDRSF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
59%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
5%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
6%
Advances
ODDS (%)
Bullish Trend 4 days ago
56%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
55%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
44%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
54%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LZAGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMIDX25.090.23
+0.93%
VALIC Company I Mid Cap Index
GSSMX34.660.22
+0.64%
Goldman Sachs Small Cap Value A
CVLOX13.560.02
+0.15%
Calamos Global Opportunities A
ADOIX18.55N/A
N/A
Axs Dynamic Opportunity I
CGVFX26.99N/A
N/A
American Funds Global Insight 529-F-1

LZAGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGY has been closely correlated with LZAGF. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LZAGY jumps, then LZAGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGY
1D Price
Change %
LZAGY100%
+0.61%
LZAGF - LZAGY
69%
Closely correlated
+6.43%
SOAGY - LZAGY
40%
Loosely correlated
-1.49%
SAUHY - LZAGY
32%
Poorly correlated
-0.04%
ESLOY - LZAGY
31%
Poorly correlated
+1.16%
RVTY - LZAGY
29%
Poorly correlated
+1.67%
More

MDRSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDRSF has been loosely correlated with STIM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MDRSF jumps, then STIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDRSF
1D Price
Change %
MDRSF100%
N/A
STIM - MDRSF
40%
Loosely correlated
+0.90%
LUCY - MDRSF
28%
Poorly correlated
+1.91%
NHNKY - MDRSF
11%
Poorly correlated
-0.08%
LZAGY - MDRSF
4%
Poorly correlated
+0.61%
NHNKF - MDRSF
0%
Poorly correlated
N/A
More